Who
Patrick Soon-Shiong
Director and Officer and 10% owner
Company insider
Files Form 4 as: Executive Chairman, ImmunityBio; 10% owner, Heliogen; Chief Executive Officer, NantHealth; Director and 10% owner, tronc; 10% owner, JAKKS Pacific; 10% owner and Other, Sorrento Therapeutics; 10% owner, Neomedia Technologies; 10% owner, KeyOn Communications Holdings.
In numbers
- Trades disclosed
- 195
- Buys
- 64
- Sells
- 19
- Bought
- $109.8M
- Sold
- $11.6M
- Companies
- 10
- Companies where not an officer
- 6
- First trade
- 22 Nov 2005
- Last trade
- 31 Mar 2026
- Last filed
- 2 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 2 Apr 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code C | $25.0M4,606,596 at $5.43 | filing |
| 31 Mar 2026filed 2 Apr 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code C | — | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —114,329 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $506K58,170 at $8.70 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —114,329 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —274,122 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $822K118,560 at $6.93 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —274,122 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —274,122 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —274,122 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $822K118,560 at $6.93 | filing |
| 22 Feb 2025filed 25 Feb 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —114,329 at $0.00 | filing |
| 22 Feb 2025filed 25 Feb 2025 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —114,329 at $0.00 | filing |
| 22 Feb 2025filed 25 Feb 2025 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $144K42,071 at $3.42 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —822,368 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —2,812,500 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —342,987 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —1,193,597 at $0.00 | filing |
| 1 Sep 2023filed 6 Sep 2023 | Heliogen | SEC FORM 4 Bought | $48K7,360 at $6.49 | filing |
| 28 Aug 2023filed 30 Aug 2023 | NantHealth | SEC FORM 4 Bought | $6.0M15,384,616 at $0.39 | filing |
News
PDS Biotech Raises Up To $22.55M In PIPE Led By Dr. Patrick Soon-Shiongrttnews.com · 8 Sep 2026ImmunityBio (NASDAQ:IBRX) Shares Down 6.4% – Here's WhyIBRX · dailypolitical.com · 19 Oct 2026
1 headline in the last 90 days name Patrick Soon-Shiong; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.